In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Animal testing

This article was originally published in The Rose Sheet

Executive Summary

Murine local lymph node assay accepted by FDA, the Environmental Protection Agency, Consumer Product Safety Commission and Occupational Safety & Health Administration as an alternative test method for contact dermatitis, the National Institutes of Health announces Dec. 28. The mouse trials can be conducted using fewer animals in most situations, NIH says. The LLNA test also results in less stress on the mice and can be conducted within a week, compared to three to four weeks for the guinea pig test. LLNA was accepted as a viable alternative to guinea pig tests by the Inter-Agency Coordinating Committee for the Validation of Alternative Methods in early 1999 and sent to the federal agencies for review (1"The Rose Sheet" March 29, 1999, p. 9). The assay is the first to clear the validation process

You may also be interested in...



Animal testing

Corrositex synthetic skin test accepted as an in vitro replacement to traditional animal tests for dermal corrosivity by the Environmental Protection Agency, Occupational Safety & Health Administration and Consumer Product Safety Commission, the National Institute's of Health's National Toxicology Program announces. The approval will be formally announced in upcoming Federal Register notices. InVitro International's Corrositex is an alternative to an existing in vivo method that involves testing several thousand laboratory rabbits each year. The Inter-Agency Coordinating Committee for the Validation of Alternative Methods unanimously recommended Corrositex in June 1999 (1"The Rose Sheet" June 28, 1999, p. 12). Corrositex is the second ICCVAM-recommended test to receive governmental approval; murine LLNA was accepted in January (2"The Rose Sheet" Jan. 10, In Brief)

Animal testing

Corrositex synthetic skin test accepted as an in vitro replacement to traditional animal tests for dermal corrosivity by the Environmental Protection Agency, Occupational Safety & Health Administration and Consumer Product Safety Commission, the National Institute's of Health's National Toxicology Program announces. The approval will be formally announced in upcoming Federal Register notices. InVitro International's Corrositex is an alternative to an existing in vivo method that involves testing several thousand laboratory rabbits each year. The Inter-Agency Coordinating Committee for the Validation of Alternative Methods unanimously recommended Corrositex in June 1999 (1"The Rose Sheet" June 28, 1999, p. 12). Corrositex is the second ICCVAM-recommended test to receive governmental approval; murine LLNA was accepted in January (2"The Rose Sheet" Jan. 10, In Brief)

California Non-Animal Testing Revised Bill To Be Introduced In February

California legislation to ban cosmetics testing on animals is being reworked to prohibit cosmetics manufacturers and contract testing laboratories from conducting animal tests when a validated alternative is available.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel